Patent · US Expired

NMDA antagonists

US5606063A · kind A · utility

5Cited by
1References
82Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 1995
Grant dateFeb 25, 1997
Priority date
Expiry dateJun 5, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D215/48
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is directed to a new class of 4-sulfanimide-quinoline derivatives and to their use as NMDA antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.